Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose versus high-dose dexmedetomidine during cardiac surgery
IRCT20170912036157N1Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in coronary arteriosclerosis and coronary artery aneurysm (CAA) (2 arms), sponsored by Rajaie Cardiovascular Medical and Research Center. Primary endpoints: Hemodynamic condition, Urine output and 9 more. Started Mar 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
coronary arteriosclerosiscoronary artery aneurysm (CAA)
Beyond the preview
Go deeper on IRCT20170912036157N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170912036157N1.